实现有效的转化科学引擎。

IF 3.1 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Cts-Clinical and Translational Science Pub Date : 2024-11-13 DOI:10.1111/cts.70069
Octavian C. Ioachimescu, Reza Shaker
{"title":"实现有效的转化科学引擎。","authors":"Octavian C. Ioachimescu,&nbsp;Reza Shaker","doi":"10.1111/cts.70069","DOIUrl":null,"url":null,"abstract":"<p>The journey of innovation and scientific discovery toward widespread clinical implementation is often meandrous, with many roadblocks, changeovers, or transitions. The traditional funded research pathway starts from ideation, request for application, and funding of the basic science or laboratory-based exploration (T0), to early-phase translational investigation in humans (T1), to clinical studies on patients in various practice settings (T2), then exploration of health in different communities (T3), to global approaches in the larger population (T4), and eventually to societal outputs via regulatory changes, policy, or new health systems' creation (T5). Unfortunately, the linear process of translation may encounter strictures at every stage of the way (Figure 1a). This is perhaps not surprising, as the linear nature of a very complex process conforms to the well-known theory of constraints, as articulated by Goldratt.<span><sup>1</sup></span> Additionally, the well-known pipeline model of translation (Figure 1a) does not include bidirectional flows of knowledge, for example, transitions from laboratory to clinic, community, or population and sometimes back to the laboratory. One can argue that the cartography of translation is not even a continuous function, as temporal disruptions may lead to dead ends, abandoned paths, wasted opportunities, unsurmountable funding gaps, or overt unrealized discoveries.</p><p>In 2011, NIH created the NCATS in order to pursue, encourage, catalyze, and grow funding opportunities for <i>disruptive translational innovation</i>, using both intra- and extramural mechanisms.<span><sup>2</sup></span> In the current NCATS' strategic plan, one aim is to accelerate translation by addressing both scientific and operational barriers, recognizing that innovation, creativity, and technology can aid and accelerate <i>translational science</i> and <i>translational research</i> efforts, including identification of new opportunities to pursue effective and efficient transitions or translations through teamwork and transdisciplinary collaboration.<span><sup>3</sup></span> Translational science is an eclectic discipline that studies the translational <i>processes and operations</i> in order to establish their scientific governing principles, mechanisms, and inner-workings, moving translation from empiricism to predictivity.<span><sup>4</sup></span> It has been asserted that moving an intervention or innovation in the well-described develop–demonstrate–disseminate cycle all the way to public health requires sometimes no &lt;20 distinct scientific disciplines, each with its own language, heuristics, frameworks, or specific outcomes.<span><sup>4, 5</sup></span></p><p>We contend that the traditional translational pipeline model can be successfully modified (Figure 1b) so that linearity and unidirectionality are corrected by a hybrid serial–parallel system of communicating vessels, with finely tuned firepower (i.e., adequate local resources, differential support gauged specifically and adaptively to overcome local bottlenecks) applied in CTSA hubs, in loco-regional or national consortia, at every phase of the investigation. This approach could allow anterograde <i>and</i> retrograde flows or “spillover” into adjacent loops (Figure 1c), augmenting the final output, and enhancing it by a strong community engagement component.<span><sup>6</sup></span> Further, we propose a modified model of Team Science approach, moving from the traditional tall, narrow, and brittle T (Translation) to a shorter, broader, and more robust T (Figure 2), centered on trans-disciplinarity<span><sup>7</sup></span> and borrowing capabilities from several specialties<span><sup>5</sup></span> that allow creating a powerful translational science engine, while strengthening the community engagement in the design, conduct, and dissemination of research. Understandably, these proposed changes to be implemented in the real world will require both local system redesigns and potentially structural changes in the future funding mechanisms.</p><p>Along the translational spectrum, adoption and dissemination of new discoveries have been marred by structural or functional challenges, barriers, system strictures, bottlenecks, chokepoints, funding winters, death valleys, or long, unexplained delays. While progress in both basic and translational research has remained highly intertwined with clinical observations, the explosive successes in fundamental laboratory research seen so far in the 21st century far outpaced clinical and translational investigation outputs.</p><p><i>Translational research</i> is defined by NCATS as the endeavor to traverse a particular step of the translational process for a specific target or disease, which aims to bridge the gap between scientific discoveries and practical, real-world applications in medicine and health care.<span><sup>8</sup></span> It often entails multidisciplinary approaches, which address several transition stages (T0-5, Figure 1) and involve moving research findings across settings, languages, methodologies, and study designs, or from laboratory to clinical practice and eventually into community- and population-level health benefits. Translational research is often used to develop novel medical devices, new therapeutic approaches, strategies, or healthcare interventions based on initial, often laboratory-based scientific discoveries. Translational research involves collaboration among scientists, clinicians, patients, community members, government officials, and other stakeholders (Team Science) to ensure that research findings are effectively translated into practice and public health policy.</p><p>In contrast, <i>translational science</i> evolved toward a separate discipline, dealing with the systematic investigation and the practice of <i>operationalizing</i> the translation of innovation from one language, ecosystem, environment, contextual landscape, phase of development, culture, scientific discipline, area, or domain into another. Translational science deals with various methodologies, technologies, and processes geared toward finding best solutions and strategies able to sustainably overcome inherent barriers or roadblocks between different phases of investigation. Translational science also encourages transdisciplinary collaborations across basic science, clinical research, epidemiology and public health, biomedical informatics, data science, and healthcare delivery. Equity-driven patient or community-centered perspectives and approaches are also central to translational science. The focus of translational science is on the efficiency, effectiveness, and informativeness of translations from laboratory (“bench”) into practical applications for patient care (“bedside” or “clinic”), to communities and populations at large, and back (the traditional “pipeline”).</p><p>The well-engrained “pipeline” concept proved to be not only a major over-simplification but, over the years and in the eyes of the public and the regulators alike, also a significant contributor to confusion, lack of understanding and inability to effectively accelerate the drug and innovation development processes. These limitations had wide implications and occasional led to counterproductive measures or approaches for science, public policy, and research funding. Recognizing the distance between simple, linear processes and very complex and meandrous paths that translational science may take, others tried to resolve the complexity of the journey of innovation by conceptualizing a drug discovery, development, and development map (4DM), which organized standard domains into networks of neighborhood activities, which can be arranged both in series and in parallel.<span><sup>9</sup></span></p><p>We contend here that a successful translational science machinery at a CTSA hub should move from multidisciplinary or interdisciplinary to transdisciplinary approaches,<span><sup>7</sup></span> and to include additional functional capabilities, smartly borrowing from other fields such as implementation science, quality improvement and management, communication sciences, marketing, system engineering, organizational psychology, human factor engineering, intervention science, data science, decision science, public health, project management, operations, change management and leadership, and working together in mixed, highly functional Team Science groups.<span><sup>5</sup></span> Development and functional use of such capabilities and competencies may serve the field of translational research well, allowing Team Science approaches to be undertaken with wider and faster adoption, more successfully and to more people.<span><sup>10</sup></span> At the institutional level, a CTSA hub can serve as designer, owner, and operator of the translational channel of communication, assuring adequate firepower and being the best catalyst for enlarging the pool of stakeholders communicating and contributing by different sets of abilities, capabilities and methodologies, in that specific channel and over specific time periods. Furthermore, in this alternative translational research model (Figure 1b), the phases of investigation can be arranged in a hybrid serial–parallel system. In contrast to the 4DM concept,<span><sup>9</sup></span> we propose here “folding” the complex neighborhood activities into locally conceived and resourced microsystems designed not only for accelerated experimentation, nimble coordination, forward and backward translation, but also for flexibility, process adaptability, and generalizability. The system resources in our own model, represented by water flow (research inputs and outputs) in the T0–T5 phases, are often not adequate for forward flow of the discovery from one communicating vessel to the next, due to the linearity of the constraints and possibly inadequate local firepower for the respective phases of investigation or loops. Figure 1c illustrates that coordinated and finely tuned firepower locally in different phases of translation through various, tactically timed and resourced requests for applications, pilot awards, specific Team Science projects (such as the ones deployed in the last year at the CTSA of Southeast Wisconsin for translational science research) may improve the bidirectional flows of knowledge, faster and more efficient adoption of new evidence and innovations.</p><p>In our traditional funding model, financial and logistic support for research generally goes to small groups of scientists or innovators, often “siloed” in specific academic units or development incubators. This may ultimately lead to profound and meaningful dives, deep hard rock drilling, or wide zooming in into the problem at hand, but often with limited breadth of expertise. This endeavor may also unveil an inherent vulnerability to breakage or fragility (tall–narrow–brittle T, Figure 2, left), due to scope, scale, technological or methodological limitations, difficulties in further testing and lack of generalizability of the findings in other contexts or phases of the translational spectrum.</p><p>In Figure 2, the tall, narrow (limited width or breadth), and brittle T represents the traditional, narrow-focus approach to research, driven by the aspiration of deep drilling or investigation (aim: depth), and narrowly fueled by specific grant mechanisms, to individual investigators or small groups. Significant roadblocks or barriers may prevent successful investigation, navigation, drilling, or dive for breakthrough discoveries. Figure 2 (middle) illustrates a short, broad (large width or breadth) and robust T, which has a better chance of success by drilling deeper, being enriched by multidisciplinary Team Science approaches. Figure 2 (right) illustrates the proposed novel model of transdisciplinary translational research (community-enhanced short–wide–robust T), constituting a powerful “press” or “engine” (aim: multipronged piercing strength), by using a broader range of capabilities, borrowing and mixing competencies and skill sets from other disciplines and fields of study, and by being community-centric. Involving patients, families, and local communities in translational research Team Science “ensembles” is crucial for ensuring meaningful outcomes, relevant impact, ethical research conduct, and effective dissemination of innovations. In our CTSA hub, we have engaged our local population members, many of them being underrepresented urban and suburban minorities, through a robust, constructive, trust-based, faith-structured community, deeply engaged in Team Science “ensembles,” in community research forums and science café sessions, leveraging the multidisciplinary skill sets and capabilities grown over the years as part of our translational science engine. We have also enriched the expertise available for the Team Science “ensembles” and pilot award investigator teams by gathering resources and faculty with various skill sets, toolboxes, frameworks, specific knowledge bases, and approaches from the contiguous specialties and disciplines. For example, we have started a transdisciplinary monthly conference on translational science and contiguous areas of study such as implementation science, system and human factors engineering, quality improvement, and design thinking, called Implementation Science for Innovation and Discovery. Operationally, we have constituted a CTSA hub Dissemination and Implementation Core (a multifaceted group with enriched knowledge bases, working in transdisciplinary approaches), which will critically appraise new and existing projects—impact and outcomes at individual, service, and implementation levels. The deliberate, declared intent in the Team Science “ensemble” approach was to activate the translational science engine in the early-forming phase and in specific translational science pilot studies, with project-based expertise customization, dedicated project management, specialized and individualized consultation for various grants or scholarly projects, and improvement projects, and by having the community members take a central role in the design and operations of these endeavors.</p><p>Translational science principles are not limited to medicine or health care and can be used in other fields, such as environmental science, engineering, and technology. Their central tenet is to ensure that scientific advancements do not remain confined to the laboratory or at the “point-of-innovation,” but are translated into practical solutions and real-life benefits that can improve people's lives. We believe that building a community-enhanced, short, wide, and robust T (translational science engine) is essential to the success of translating research findings and innovations into practice, to communities and populations at large, and it may require equipping CTSA hubs with specific capabilities via borrowing, developing, and/or consulting with specialists from very different and sometimes overlapping domains, fields, or disciplines, and to center the investigative efforts on a robust community engagement component. Successful transformation in the CTSA hubs does not require following predefined, unique recipes, but will necessitate significant redesign, to include system human interfaces with additional transdisciplinary, broader capabilities, robust community stakeholder involvement and active participation, and also diversification of the local support structures and pilot awards geared toward translational science projects, together with national, broader funding mechanisms that could strengthen these new systems and functional capabilities.</p><p>NCATS—CTSA: FP00015891; PI: Reza Shaker.</p><p>The authors declared no competing interests for this work.</p>","PeriodicalId":50610,"journal":{"name":"Cts-Clinical and Translational Science","volume":"17 11","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11561134/pdf/","citationCount":"0","resultStr":"{\"title\":\"Toward an effective translational science engine\",\"authors\":\"Octavian C. Ioachimescu,&nbsp;Reza Shaker\",\"doi\":\"10.1111/cts.70069\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The journey of innovation and scientific discovery toward widespread clinical implementation is often meandrous, with many roadblocks, changeovers, or transitions. The traditional funded research pathway starts from ideation, request for application, and funding of the basic science or laboratory-based exploration (T0), to early-phase translational investigation in humans (T1), to clinical studies on patients in various practice settings (T2), then exploration of health in different communities (T3), to global approaches in the larger population (T4), and eventually to societal outputs via regulatory changes, policy, or new health systems' creation (T5). Unfortunately, the linear process of translation may encounter strictures at every stage of the way (Figure 1a). This is perhaps not surprising, as the linear nature of a very complex process conforms to the well-known theory of constraints, as articulated by Goldratt.<span><sup>1</sup></span> Additionally, the well-known pipeline model of translation (Figure 1a) does not include bidirectional flows of knowledge, for example, transitions from laboratory to clinic, community, or population and sometimes back to the laboratory. One can argue that the cartography of translation is not even a continuous function, as temporal disruptions may lead to dead ends, abandoned paths, wasted opportunities, unsurmountable funding gaps, or overt unrealized discoveries.</p><p>In 2011, NIH created the NCATS in order to pursue, encourage, catalyze, and grow funding opportunities for <i>disruptive translational innovation</i>, using both intra- and extramural mechanisms.<span><sup>2</sup></span> In the current NCATS' strategic plan, one aim is to accelerate translation by addressing both scientific and operational barriers, recognizing that innovation, creativity, and technology can aid and accelerate <i>translational science</i> and <i>translational research</i> efforts, including identification of new opportunities to pursue effective and efficient transitions or translations through teamwork and transdisciplinary collaboration.<span><sup>3</sup></span> Translational science is an eclectic discipline that studies the translational <i>processes and operations</i> in order to establish their scientific governing principles, mechanisms, and inner-workings, moving translation from empiricism to predictivity.<span><sup>4</sup></span> It has been asserted that moving an intervention or innovation in the well-described develop–demonstrate–disseminate cycle all the way to public health requires sometimes no &lt;20 distinct scientific disciplines, each with its own language, heuristics, frameworks, or specific outcomes.<span><sup>4, 5</sup></span></p><p>We contend that the traditional translational pipeline model can be successfully modified (Figure 1b) so that linearity and unidirectionality are corrected by a hybrid serial–parallel system of communicating vessels, with finely tuned firepower (i.e., adequate local resources, differential support gauged specifically and adaptively to overcome local bottlenecks) applied in CTSA hubs, in loco-regional or national consortia, at every phase of the investigation. This approach could allow anterograde <i>and</i> retrograde flows or “spillover” into adjacent loops (Figure 1c), augmenting the final output, and enhancing it by a strong community engagement component.<span><sup>6</sup></span> Further, we propose a modified model of Team Science approach, moving from the traditional tall, narrow, and brittle T (Translation) to a shorter, broader, and more robust T (Figure 2), centered on trans-disciplinarity<span><sup>7</sup></span> and borrowing capabilities from several specialties<span><sup>5</sup></span> that allow creating a powerful translational science engine, while strengthening the community engagement in the design, conduct, and dissemination of research. Understandably, these proposed changes to be implemented in the real world will require both local system redesigns and potentially structural changes in the future funding mechanisms.</p><p>Along the translational spectrum, adoption and dissemination of new discoveries have been marred by structural or functional challenges, barriers, system strictures, bottlenecks, chokepoints, funding winters, death valleys, or long, unexplained delays. While progress in both basic and translational research has remained highly intertwined with clinical observations, the explosive successes in fundamental laboratory research seen so far in the 21st century far outpaced clinical and translational investigation outputs.</p><p><i>Translational research</i> is defined by NCATS as the endeavor to traverse a particular step of the translational process for a specific target or disease, which aims to bridge the gap between scientific discoveries and practical, real-world applications in medicine and health care.<span><sup>8</sup></span> It often entails multidisciplinary approaches, which address several transition stages (T0-5, Figure 1) and involve moving research findings across settings, languages, methodologies, and study designs, or from laboratory to clinical practice and eventually into community- and population-level health benefits. Translational research is often used to develop novel medical devices, new therapeutic approaches, strategies, or healthcare interventions based on initial, often laboratory-based scientific discoveries. Translational research involves collaboration among scientists, clinicians, patients, community members, government officials, and other stakeholders (Team Science) to ensure that research findings are effectively translated into practice and public health policy.</p><p>In contrast, <i>translational science</i> evolved toward a separate discipline, dealing with the systematic investigation and the practice of <i>operationalizing</i> the translation of innovation from one language, ecosystem, environment, contextual landscape, phase of development, culture, scientific discipline, area, or domain into another. Translational science deals with various methodologies, technologies, and processes geared toward finding best solutions and strategies able to sustainably overcome inherent barriers or roadblocks between different phases of investigation. Translational science also encourages transdisciplinary collaborations across basic science, clinical research, epidemiology and public health, biomedical informatics, data science, and healthcare delivery. Equity-driven patient or community-centered perspectives and approaches are also central to translational science. The focus of translational science is on the efficiency, effectiveness, and informativeness of translations from laboratory (“bench”) into practical applications for patient care (“bedside” or “clinic”), to communities and populations at large, and back (the traditional “pipeline”).</p><p>The well-engrained “pipeline” concept proved to be not only a major over-simplification but, over the years and in the eyes of the public and the regulators alike, also a significant contributor to confusion, lack of understanding and inability to effectively accelerate the drug and innovation development processes. These limitations had wide implications and occasional led to counterproductive measures or approaches for science, public policy, and research funding. Recognizing the distance between simple, linear processes and very complex and meandrous paths that translational science may take, others tried to resolve the complexity of the journey of innovation by conceptualizing a drug discovery, development, and development map (4DM), which organized standard domains into networks of neighborhood activities, which can be arranged both in series and in parallel.<span><sup>9</sup></span></p><p>We contend here that a successful translational science machinery at a CTSA hub should move from multidisciplinary or interdisciplinary to transdisciplinary approaches,<span><sup>7</sup></span> and to include additional functional capabilities, smartly borrowing from other fields such as implementation science, quality improvement and management, communication sciences, marketing, system engineering, organizational psychology, human factor engineering, intervention science, data science, decision science, public health, project management, operations, change management and leadership, and working together in mixed, highly functional Team Science groups.<span><sup>5</sup></span> Development and functional use of such capabilities and competencies may serve the field of translational research well, allowing Team Science approaches to be undertaken with wider and faster adoption, more successfully and to more people.<span><sup>10</sup></span> At the institutional level, a CTSA hub can serve as designer, owner, and operator of the translational channel of communication, assuring adequate firepower and being the best catalyst for enlarging the pool of stakeholders communicating and contributing by different sets of abilities, capabilities and methodologies, in that specific channel and over specific time periods. Furthermore, in this alternative translational research model (Figure 1b), the phases of investigation can be arranged in a hybrid serial–parallel system. In contrast to the 4DM concept,<span><sup>9</sup></span> we propose here “folding” the complex neighborhood activities into locally conceived and resourced microsystems designed not only for accelerated experimentation, nimble coordination, forward and backward translation, but also for flexibility, process adaptability, and generalizability. The system resources in our own model, represented by water flow (research inputs and outputs) in the T0–T5 phases, are often not adequate for forward flow of the discovery from one communicating vessel to the next, due to the linearity of the constraints and possibly inadequate local firepower for the respective phases of investigation or loops. Figure 1c illustrates that coordinated and finely tuned firepower locally in different phases of translation through various, tactically timed and resourced requests for applications, pilot awards, specific Team Science projects (such as the ones deployed in the last year at the CTSA of Southeast Wisconsin for translational science research) may improve the bidirectional flows of knowledge, faster and more efficient adoption of new evidence and innovations.</p><p>In our traditional funding model, financial and logistic support for research generally goes to small groups of scientists or innovators, often “siloed” in specific academic units or development incubators. This may ultimately lead to profound and meaningful dives, deep hard rock drilling, or wide zooming in into the problem at hand, but often with limited breadth of expertise. This endeavor may also unveil an inherent vulnerability to breakage or fragility (tall–narrow–brittle T, Figure 2, left), due to scope, scale, technological or methodological limitations, difficulties in further testing and lack of generalizability of the findings in other contexts or phases of the translational spectrum.</p><p>In Figure 2, the tall, narrow (limited width or breadth), and brittle T represents the traditional, narrow-focus approach to research, driven by the aspiration of deep drilling or investigation (aim: depth), and narrowly fueled by specific grant mechanisms, to individual investigators or small groups. Significant roadblocks or barriers may prevent successful investigation, navigation, drilling, or dive for breakthrough discoveries. Figure 2 (middle) illustrates a short, broad (large width or breadth) and robust T, which has a better chance of success by drilling deeper, being enriched by multidisciplinary Team Science approaches. Figure 2 (right) illustrates the proposed novel model of transdisciplinary translational research (community-enhanced short–wide–robust T), constituting a powerful “press” or “engine” (aim: multipronged piercing strength), by using a broader range of capabilities, borrowing and mixing competencies and skill sets from other disciplines and fields of study, and by being community-centric. Involving patients, families, and local communities in translational research Team Science “ensembles” is crucial for ensuring meaningful outcomes, relevant impact, ethical research conduct, and effective dissemination of innovations. In our CTSA hub, we have engaged our local population members, many of them being underrepresented urban and suburban minorities, through a robust, constructive, trust-based, faith-structured community, deeply engaged in Team Science “ensembles,” in community research forums and science café sessions, leveraging the multidisciplinary skill sets and capabilities grown over the years as part of our translational science engine. We have also enriched the expertise available for the Team Science “ensembles” and pilot award investigator teams by gathering resources and faculty with various skill sets, toolboxes, frameworks, specific knowledge bases, and approaches from the contiguous specialties and disciplines. For example, we have started a transdisciplinary monthly conference on translational science and contiguous areas of study such as implementation science, system and human factors engineering, quality improvement, and design thinking, called Implementation Science for Innovation and Discovery. Operationally, we have constituted a CTSA hub Dissemination and Implementation Core (a multifaceted group with enriched knowledge bases, working in transdisciplinary approaches), which will critically appraise new and existing projects—impact and outcomes at individual, service, and implementation levels. The deliberate, declared intent in the Team Science “ensemble” approach was to activate the translational science engine in the early-forming phase and in specific translational science pilot studies, with project-based expertise customization, dedicated project management, specialized and individualized consultation for various grants or scholarly projects, and improvement projects, and by having the community members take a central role in the design and operations of these endeavors.</p><p>Translational science principles are not limited to medicine or health care and can be used in other fields, such as environmental science, engineering, and technology. Their central tenet is to ensure that scientific advancements do not remain confined to the laboratory or at the “point-of-innovation,” but are translated into practical solutions and real-life benefits that can improve people's lives. We believe that building a community-enhanced, short, wide, and robust T (translational science engine) is essential to the success of translating research findings and innovations into practice, to communities and populations at large, and it may require equipping CTSA hubs with specific capabilities via borrowing, developing, and/or consulting with specialists from very different and sometimes overlapping domains, fields, or disciplines, and to center the investigative efforts on a robust community engagement component. Successful transformation in the CTSA hubs does not require following predefined, unique recipes, but will necessitate significant redesign, to include system human interfaces with additional transdisciplinary, broader capabilities, robust community stakeholder involvement and active participation, and also diversification of the local support structures and pilot awards geared toward translational science projects, together with national, broader funding mechanisms that could strengthen these new systems and functional capabilities.</p><p>NCATS—CTSA: FP00015891; PI: Reza Shaker.</p><p>The authors declared no competing interests for this work.</p>\",\"PeriodicalId\":50610,\"journal\":{\"name\":\"Cts-Clinical and Translational Science\",\"volume\":\"17 11\",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2024-11-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11561134/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cts-Clinical and Translational Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/cts.70069\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cts-Clinical and Translational Science","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cts.70069","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

转化研究通常用于开发新型医疗设备、新的治疗方法、策略或医疗保健干预措施,其基础是最初的、通常是基于实验室的科学发现。转化研究涉及科学家、临床医生、患者、社区成员、政府官员和其他利益相关者(团队科学)之间的合作,以确保研究成果有效地转化为实践和公共卫生政策。相比之下,转化科学逐渐发展成为一门独立的学科,涉及将创新从一种语言、生态系统、环境、背景景观、发展阶段、文化、科学学科、领域或领域转化为另一种语言、生态系统、环境、背景景观、发展阶段、文化、科学学科、领域或领域的系统研究和实践操作。转化科学涉及各种方法、技术和流程,旨在找到能够持续克服不同调查阶段之间固有障碍或路障的最佳解决方案和战略。转化科学还鼓励基础科学、临床研究、流行病学和公共卫生、生物医学信息学、数据科学和医疗保健服务之间的跨学科合作。以公平为导向、以患者或社区为中心的观点和方法也是转化科学的核心。转化科学的重点在于从实验室("工作台")转化为病人护理("床边 "或 "诊所")、社区和广大人群的实际应用以及再转化(传统的 "流水线")的效率、有效性和信息化。事实证明,根深蒂固的 "流水线 "概念不仅严重过度简化,而且多年来在公众和监管机构眼中,也是造成混乱、缺乏理解以及无法有效加快药物和创新开发进程的重要因素。这些局限性产生了广泛的影响,有时会导致科学、公共政策和研究经费方面的措施或方法适得其反。由于认识到简单的线性过程与转化科学可能走过的非常复杂和奇妙的道路之间的距离,其他人试图通过药物发现、开发和研制地图(4DM)的概念化来解决创新历程的复杂性,该地图将标准领域组织成邻域活动网络,既可以串联,也可以并联。我们在此认为,CTSA 中心的成功转化科学机制应从多学科或跨学科方法转向跨学科方法,7 并包括更多的功能能力,巧妙地借鉴其他领域,如实施科学、质量改进和管理、传播科学、市场营销、系统工程、组织心理学、人因工程、干预科学、数据科学、决策科学、公共卫生、项目管理、运营、变革管理和领导力,并在混合的、功能性很强的团队科学小组中合作。10 在机构层面,CTSA 中心可以充当转化交流渠道的设计者、所有者和操作者,确保足够的火力,并成为最佳催化剂,以扩大在特定渠道和特定时间段内通过不同的能力、才干和方法进行交流和做出贡献的利益相关者群体。此外,在这种可供选择的转化研究模式中(图 1b),调查阶段可以安排在一个串行-并行混合系统中。与 4DM 概念相反9 ,我们在此建议将复杂的邻域活动 "折叠 "成本地构思和资源的微系统,这些微系统不仅旨在加速实验、灵活协调、前向和后向转化,而且还具有灵活性、过程适应性和可推广性。在我们自己的模型中,T0-T5 阶段的水流(研究输入和输出)所代表的系统资源,往往不足以将发现从一个交流容器向前流动到下一个容器,这是由于限制因素的线性关系,以及可能没有足够的本地火力进行相应阶段的调查或循环。 图 1c 显示,在转化的不同阶段,通过各种有策略、有时间和资源安排的申请、试点奖励、具体的团队科学项目(如去年在威斯康星州东南部的转化科学研究中心部署的项目),在当地协调和微调火力,可以改善知识的双向流动,更快、更有效地采用新证据和创新。在我们传统的资助模式中,对研究的资金和后勤支持通常提供给一小部分科学家或创新者,他们往往被 "孤立 "在特定的学术单位或发展孵化器中。这最终可能会导致对当前问题进行深刻而有意义的挖掘、深层硬岩钻探或广泛放大,但专业知识的广度往往有限。由于范围、规模、技术或方法上的限制,进一步测试的困难,以及研究结果在转化过程的其他背景或阶段缺乏普遍性,这种努力也可能揭示出内在的脆弱性,即易碎性(高-窄-脆 T,图 2,左)。在图 2 中,高、窄(宽度或广度有限)、脆的 T 代表传统的、重点狭窄的研究方法,由深入钻研或调查(目标:深度)的愿望所驱动,并由特定的资助机制提供狭隘的动力,以个体研究者或小团体为对象。重大的路障或障碍可能会阻碍成功的调查、导航、钻探或潜水以获得突破性发现。图 2(中)展示了一个短小、宽广(大宽度或广度)和稳健的 T,通过多学科团队科学方法的充实,深入钻研,成功的机会更大。图 2(右)展示了拟议的跨学科转化研究新模式(社区增强型短宽强 T),通过利用更广泛的能力、借用和混合其他学科和研究领域的能力和技能组合以及以社区为中心,构成强大的 "压力机 "或 "发动机"(目的:多管齐下的穿刺力量)。让患者、家庭和当地社区参与到转化研究团队科学 "组合 "中,对于确保有意义的成果、相关的影响、合乎道德的研究行为以及创新成果的有效传播至关重要。在我们的 CTSA 中心,我们通过一个强大的、有建设性的、以信任为基础的、有信仰结构的社区,让当地居民(其中许多人是代表人数不足的城市和郊区少数民族)深入参与团队科学 "组合",参加社区研究论坛和科学咖啡馆会议,充分利用多年来作为我们转化科学引擎的一部分而发展起来的多学科技能组合和能力。我们还通过汇聚资源和师资,丰富了团队科学 "组合 "和试点奖研究人员团队的专业知识,这些资源和师资拥有各种技能组合、工具箱、框架、特定知识库,以及来自相关专业和学科的方法。例如,我们已经启动了一个跨学科月度会议,讨论转化科学以及实施科学、系统和人因工程、质量改进和设计思维等相关研究领域,名为 "实施科学促进创新和发现"。在业务上,我们组建了一个 CTSA 中心传播与实施核心小组(一个拥有丰富知识库、以跨学科方法开展工作的多元化小组),该小组将对新项目和现有项目--在个人、服务和实施层面的影响和成果--进行严格评估。团队科学 "合奏 "方法特意宣布的意图是,在早期形成阶段和具体的转化科学试点研究中,通过以项目为基础的专业知识定制、专门的项目管理、针对各种补助金或学术项目以及改进项目的专业化和个性化咨询,并通过让社区成员在这些努力的设计和运作中发挥核心作用,激活转化科学引擎。其核心原则是确保科学进步不局限于实验室或 "创新点",而是转化为可改善人们生活的实际解决方案和现实利益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Toward an effective translational science engine

The journey of innovation and scientific discovery toward widespread clinical implementation is often meandrous, with many roadblocks, changeovers, or transitions. The traditional funded research pathway starts from ideation, request for application, and funding of the basic science or laboratory-based exploration (T0), to early-phase translational investigation in humans (T1), to clinical studies on patients in various practice settings (T2), then exploration of health in different communities (T3), to global approaches in the larger population (T4), and eventually to societal outputs via regulatory changes, policy, or new health systems' creation (T5). Unfortunately, the linear process of translation may encounter strictures at every stage of the way (Figure 1a). This is perhaps not surprising, as the linear nature of a very complex process conforms to the well-known theory of constraints, as articulated by Goldratt.1 Additionally, the well-known pipeline model of translation (Figure 1a) does not include bidirectional flows of knowledge, for example, transitions from laboratory to clinic, community, or population and sometimes back to the laboratory. One can argue that the cartography of translation is not even a continuous function, as temporal disruptions may lead to dead ends, abandoned paths, wasted opportunities, unsurmountable funding gaps, or overt unrealized discoveries.

In 2011, NIH created the NCATS in order to pursue, encourage, catalyze, and grow funding opportunities for disruptive translational innovation, using both intra- and extramural mechanisms.2 In the current NCATS' strategic plan, one aim is to accelerate translation by addressing both scientific and operational barriers, recognizing that innovation, creativity, and technology can aid and accelerate translational science and translational research efforts, including identification of new opportunities to pursue effective and efficient transitions or translations through teamwork and transdisciplinary collaboration.3 Translational science is an eclectic discipline that studies the translational processes and operations in order to establish their scientific governing principles, mechanisms, and inner-workings, moving translation from empiricism to predictivity.4 It has been asserted that moving an intervention or innovation in the well-described develop–demonstrate–disseminate cycle all the way to public health requires sometimes no <20 distinct scientific disciplines, each with its own language, heuristics, frameworks, or specific outcomes.4, 5

We contend that the traditional translational pipeline model can be successfully modified (Figure 1b) so that linearity and unidirectionality are corrected by a hybrid serial–parallel system of communicating vessels, with finely tuned firepower (i.e., adequate local resources, differential support gauged specifically and adaptively to overcome local bottlenecks) applied in CTSA hubs, in loco-regional or national consortia, at every phase of the investigation. This approach could allow anterograde and retrograde flows or “spillover” into adjacent loops (Figure 1c), augmenting the final output, and enhancing it by a strong community engagement component.6 Further, we propose a modified model of Team Science approach, moving from the traditional tall, narrow, and brittle T (Translation) to a shorter, broader, and more robust T (Figure 2), centered on trans-disciplinarity7 and borrowing capabilities from several specialties5 that allow creating a powerful translational science engine, while strengthening the community engagement in the design, conduct, and dissemination of research. Understandably, these proposed changes to be implemented in the real world will require both local system redesigns and potentially structural changes in the future funding mechanisms.

Along the translational spectrum, adoption and dissemination of new discoveries have been marred by structural or functional challenges, barriers, system strictures, bottlenecks, chokepoints, funding winters, death valleys, or long, unexplained delays. While progress in both basic and translational research has remained highly intertwined with clinical observations, the explosive successes in fundamental laboratory research seen so far in the 21st century far outpaced clinical and translational investigation outputs.

Translational research is defined by NCATS as the endeavor to traverse a particular step of the translational process for a specific target or disease, which aims to bridge the gap between scientific discoveries and practical, real-world applications in medicine and health care.8 It often entails multidisciplinary approaches, which address several transition stages (T0-5, Figure 1) and involve moving research findings across settings, languages, methodologies, and study designs, or from laboratory to clinical practice and eventually into community- and population-level health benefits. Translational research is often used to develop novel medical devices, new therapeutic approaches, strategies, or healthcare interventions based on initial, often laboratory-based scientific discoveries. Translational research involves collaboration among scientists, clinicians, patients, community members, government officials, and other stakeholders (Team Science) to ensure that research findings are effectively translated into practice and public health policy.

In contrast, translational science evolved toward a separate discipline, dealing with the systematic investigation and the practice of operationalizing the translation of innovation from one language, ecosystem, environment, contextual landscape, phase of development, culture, scientific discipline, area, or domain into another. Translational science deals with various methodologies, technologies, and processes geared toward finding best solutions and strategies able to sustainably overcome inherent barriers or roadblocks between different phases of investigation. Translational science also encourages transdisciplinary collaborations across basic science, clinical research, epidemiology and public health, biomedical informatics, data science, and healthcare delivery. Equity-driven patient or community-centered perspectives and approaches are also central to translational science. The focus of translational science is on the efficiency, effectiveness, and informativeness of translations from laboratory (“bench”) into practical applications for patient care (“bedside” or “clinic”), to communities and populations at large, and back (the traditional “pipeline”).

The well-engrained “pipeline” concept proved to be not only a major over-simplification but, over the years and in the eyes of the public and the regulators alike, also a significant contributor to confusion, lack of understanding and inability to effectively accelerate the drug and innovation development processes. These limitations had wide implications and occasional led to counterproductive measures or approaches for science, public policy, and research funding. Recognizing the distance between simple, linear processes and very complex and meandrous paths that translational science may take, others tried to resolve the complexity of the journey of innovation by conceptualizing a drug discovery, development, and development map (4DM), which organized standard domains into networks of neighborhood activities, which can be arranged both in series and in parallel.9

We contend here that a successful translational science machinery at a CTSA hub should move from multidisciplinary or interdisciplinary to transdisciplinary approaches,7 and to include additional functional capabilities, smartly borrowing from other fields such as implementation science, quality improvement and management, communication sciences, marketing, system engineering, organizational psychology, human factor engineering, intervention science, data science, decision science, public health, project management, operations, change management and leadership, and working together in mixed, highly functional Team Science groups.5 Development and functional use of such capabilities and competencies may serve the field of translational research well, allowing Team Science approaches to be undertaken with wider and faster adoption, more successfully and to more people.10 At the institutional level, a CTSA hub can serve as designer, owner, and operator of the translational channel of communication, assuring adequate firepower and being the best catalyst for enlarging the pool of stakeholders communicating and contributing by different sets of abilities, capabilities and methodologies, in that specific channel and over specific time periods. Furthermore, in this alternative translational research model (Figure 1b), the phases of investigation can be arranged in a hybrid serial–parallel system. In contrast to the 4DM concept,9 we propose here “folding” the complex neighborhood activities into locally conceived and resourced microsystems designed not only for accelerated experimentation, nimble coordination, forward and backward translation, but also for flexibility, process adaptability, and generalizability. The system resources in our own model, represented by water flow (research inputs and outputs) in the T0–T5 phases, are often not adequate for forward flow of the discovery from one communicating vessel to the next, due to the linearity of the constraints and possibly inadequate local firepower for the respective phases of investigation or loops. Figure 1c illustrates that coordinated and finely tuned firepower locally in different phases of translation through various, tactically timed and resourced requests for applications, pilot awards, specific Team Science projects (such as the ones deployed in the last year at the CTSA of Southeast Wisconsin for translational science research) may improve the bidirectional flows of knowledge, faster and more efficient adoption of new evidence and innovations.

In our traditional funding model, financial and logistic support for research generally goes to small groups of scientists or innovators, often “siloed” in specific academic units or development incubators. This may ultimately lead to profound and meaningful dives, deep hard rock drilling, or wide zooming in into the problem at hand, but often with limited breadth of expertise. This endeavor may also unveil an inherent vulnerability to breakage or fragility (tall–narrow–brittle T, Figure 2, left), due to scope, scale, technological or methodological limitations, difficulties in further testing and lack of generalizability of the findings in other contexts or phases of the translational spectrum.

In Figure 2, the tall, narrow (limited width or breadth), and brittle T represents the traditional, narrow-focus approach to research, driven by the aspiration of deep drilling or investigation (aim: depth), and narrowly fueled by specific grant mechanisms, to individual investigators or small groups. Significant roadblocks or barriers may prevent successful investigation, navigation, drilling, or dive for breakthrough discoveries. Figure 2 (middle) illustrates a short, broad (large width or breadth) and robust T, which has a better chance of success by drilling deeper, being enriched by multidisciplinary Team Science approaches. Figure 2 (right) illustrates the proposed novel model of transdisciplinary translational research (community-enhanced short–wide–robust T), constituting a powerful “press” or “engine” (aim: multipronged piercing strength), by using a broader range of capabilities, borrowing and mixing competencies and skill sets from other disciplines and fields of study, and by being community-centric. Involving patients, families, and local communities in translational research Team Science “ensembles” is crucial for ensuring meaningful outcomes, relevant impact, ethical research conduct, and effective dissemination of innovations. In our CTSA hub, we have engaged our local population members, many of them being underrepresented urban and suburban minorities, through a robust, constructive, trust-based, faith-structured community, deeply engaged in Team Science “ensembles,” in community research forums and science café sessions, leveraging the multidisciplinary skill sets and capabilities grown over the years as part of our translational science engine. We have also enriched the expertise available for the Team Science “ensembles” and pilot award investigator teams by gathering resources and faculty with various skill sets, toolboxes, frameworks, specific knowledge bases, and approaches from the contiguous specialties and disciplines. For example, we have started a transdisciplinary monthly conference on translational science and contiguous areas of study such as implementation science, system and human factors engineering, quality improvement, and design thinking, called Implementation Science for Innovation and Discovery. Operationally, we have constituted a CTSA hub Dissemination and Implementation Core (a multifaceted group with enriched knowledge bases, working in transdisciplinary approaches), which will critically appraise new and existing projects—impact and outcomes at individual, service, and implementation levels. The deliberate, declared intent in the Team Science “ensemble” approach was to activate the translational science engine in the early-forming phase and in specific translational science pilot studies, with project-based expertise customization, dedicated project management, specialized and individualized consultation for various grants or scholarly projects, and improvement projects, and by having the community members take a central role in the design and operations of these endeavors.

Translational science principles are not limited to medicine or health care and can be used in other fields, such as environmental science, engineering, and technology. Their central tenet is to ensure that scientific advancements do not remain confined to the laboratory or at the “point-of-innovation,” but are translated into practical solutions and real-life benefits that can improve people's lives. We believe that building a community-enhanced, short, wide, and robust T (translational science engine) is essential to the success of translating research findings and innovations into practice, to communities and populations at large, and it may require equipping CTSA hubs with specific capabilities via borrowing, developing, and/or consulting with specialists from very different and sometimes overlapping domains, fields, or disciplines, and to center the investigative efforts on a robust community engagement component. Successful transformation in the CTSA hubs does not require following predefined, unique recipes, but will necessitate significant redesign, to include system human interfaces with additional transdisciplinary, broader capabilities, robust community stakeholder involvement and active participation, and also diversification of the local support structures and pilot awards geared toward translational science projects, together with national, broader funding mechanisms that could strengthen these new systems and functional capabilities.

NCATS—CTSA: FP00015891; PI: Reza Shaker.

The authors declared no competing interests for this work.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cts-Clinical and Translational Science
Cts-Clinical and Translational Science 医学-医学:研究与实验
CiteScore
6.70
自引率
2.60%
发文量
234
审稿时长
6-12 weeks
期刊介绍: Clinical and Translational Science (CTS), an official journal of the American Society for Clinical Pharmacology and Therapeutics, highlights original translational medicine research that helps bridge laboratory discoveries with the diagnosis and treatment of human disease. Translational medicine is a multi-faceted discipline with a focus on translational therapeutics. In a broad sense, translational medicine bridges across the discovery, development, regulation, and utilization spectrum. Research may appear as Full Articles, Brief Reports, Commentaries, Phase Forwards (clinical trials), Reviews, or Tutorials. CTS also includes invited didactic content that covers the connections between clinical pharmacology and translational medicine. Best-in-class methodologies and best practices are also welcomed as Tutorials. These additional features provide context for research articles and facilitate understanding for a wide array of individuals interested in clinical and translational science. CTS welcomes high quality, scientifically sound, original manuscripts focused on clinical pharmacology and translational science, including animal, in vitro, in silico, and clinical studies supporting the breadth of drug discovery, development, regulation and clinical use of both traditional drugs and innovative modalities.
期刊最新文献
Use cases of registry-based randomized controlled trials—A review of the registries' contributions and constraints Integrating real-world data and machine learning: A framework to assess covariate importance in real-world use of alternative intravenous dosing regimens for atezolizumab High-dose intranasal insulin in an adaptive dose-escalation study in healthy human participants Accumulation of endogenous Muse cells in the myocardium and its pathophysiological role in patients with fulminant myocarditis A randomized, placebo-controlled first-in-human study of oral TQS-168 in healthy volunteers: Assessment of safety, tolerability, pharmacokinetics, pharmacodynamics, and food effect
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1